Synthesis and anti-diabetic activity of (RS)-2-ethoxy-3-{4-[2-(4-trifluoro-8methanesulfonyloxy-phenyl)-ethoxy]-phenyl}- propionic acid

Acta Pharmacologica Sinica

Volumn 27, Issue 5, 2006, Pages 597-602

  Cai, Zhe Feng ^a   Liu, Quan ^a   Li, Ping Ping ^a   Guo, Zong Ru ^a   Shen, Zhu Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Agonists; Hypoglycemic agents; Peroxisome proliferator activated receptors

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; ROSIGLITAZONE; TESAGLITAZAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; GLUCOSE METABOLISM; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID METABOLISM; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RECEPTOR AFFINITY; REPORTER GENE; TASK PERFORMANCE;

ANIMALS; ARYLSULFONATES; BLOOD GLUCOSE; BONE NEOPLASMS; CELL LINE, TUMOR; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; OSTEOSARCOMA; PHENYLPROPIONATES; PPAR ALPHA; PPAR-BETA; PYRIMIDINES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 33646227447     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00295.x     Document Type: Article

References (20)

1. Port DJ Schwartz MW. Diabetes complications: why is glucose potentially toxic Science 1996 27 699 700
2. Ding SY Shen ZF Chen YT Sun SJ Liu Quan Xie MZ Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats Acta Pharmacol Sin 2005 26 575 80
3. Berger J David E. The mechanisms of action of PPARs Annu Rev Med 2002 53 409 35
4. Barry GS William JH. Recent advances in peroxisome proliferator-activated receptor science Curr Med Chem 2003 10 267 80
5. Torra IP Gervois P Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging Curr Opin Lipidol 1999 10 151 60
6. Staels B Dallongeville J Auwerx J Schoonjans K Leitersdorf E Fruchart JC et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 1998 98 2088 93
7. Chaput E Saladin R Silvestre M Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight Biochem Biophys Res Commun 2000 271 445 50
8. Lehmann JM Moore LB Smith-Oliver TA Wilkison WO Willson TM Kliewer SA et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor γ (PPARγ) J Biol Chem 1995 270 12953 6
9. Willlson TM Cobb JE Cowan DJ Wiethe RW Correa ID Prakash SR et al. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones J Med Chem 1996 39 665 8
10. Aronoff S Rosenblatt S Braithwaite S Egan JW Mathisen AL Schneider RL et al. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study Diabetes Care 2000 23 1605 11
11. Mathisen AL Brockley MR. The relationship of HbA1c and weight in the treatment of patients with type 2 diabetes Diabetes 2000 49 Suppl 1 A117
12. Brooks DA Etgen GJ Rito CJ Shuker AJ Dominianni SJ Warshawsky AM et al. Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: a new class of dual PPAR α/γ agonists J Med Chem 2001 44 2061 4
13. Desai RC Han W Metzger EJ Bergman JP Gratale DF MacNaul KL et al. 5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents Bioorg Med Chem Lett 2003 13 2795 8
14. Ebdrup S Pettersson I Rasmussen HB Deussen HJ Jensen AF Mortensen SB et al. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor α/γ agonist ragaglitazar J Med Chem 2003 46 1306 17
15. Li Z Liao C Ko BC Shan S Tong EH Yin ZH et al. Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators Bioorg Med Chem Lett 2004 14 3507 11
16. Iwatsuka H Shino A Suzuoki Z. General survey of diabetic features of yellow KK mice Endocrinol Jpn 1970 17 23 5
17. Shimamura M Hazato T Ashino H Yamamoto Y Iwasaki E Tobe H et al. Inhibition of angiogenesis by humulone, a bitter acid from beer hop Biochem Biophys Res Commun 2001 289 220 4
18. Yamamoto K Wang J Yamamoto S Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid FEBS Lett 2000 465 103 6
19. Ljung B Bamberg K Dahllof B Kjellstedt A Oakes ND Ostling J et al. AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats J Lipid Res 2002 43 1855 63
20. Murakami K Tobe K Ide T Mochizuki T Ohashi M Akanuma Y et al. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats Diabetes 1998 47 1841 7